3.41 USD
▼-0.02-0.58%
盘后 3.43 +0.59%
2026-09-15
市值
$382.02M
市盈率
—
EPS
-0.15
股息率
—
52 周区间
2.53 – 5.45
成交量
3.66M
Beta
0.50
目标价
8.84
52W 低 2.5352W 高 5.45
价格走势
公司简介
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing, manufacturing, and selling of genetic therapies for rare and devastating diseases in the United States. It develops in vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inheritable cardia...